cagrilintide contraindications Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study Cagrilintide is an amylin analogue
Description
Its a research peptide that interacts with biological pathways to promote healing at the cellular level
(2012) 302:G48492
& Takakura, Y
There was a possibly significant decrease (improvement) in RBC iron, from a level above the average of the neurotypicals to a level slightly lower than the neurotypical average
